Min menu


Latest News [LastPost]

British scientists are conducting a study of new drugs that prevent blood clots caused by corona

The Daily Express website revealed that the Corona virus vaccine is very safe for the vast majority of people, but in a very rare few cases, there have been some cases of blood clots in the brain, this type of blood clotting is known as cerebral venous thrombosis (CVT) and can lead to strokes cerebral palsy.

Researchers at University College London conducted a study of people with CVT after vaccination, to provide a clearer guide for clinicians trying to diagnose and treat these patients.

The research, published in The Lancet, is the most detailed account of the characteristics of CVT, when it is caused by the new case of vaccinia-induced thrombocytopenia (VITT).

Scientists from John Radcliffe Hospital in Oxford looked at the details of 70 patients with CVT associated with VITT after vaccination, and compared these patients to 25 patients with CVT.

Their study provides 3 principles of treatment that have been established so far by a panel of hematologists.

These include the use of non-heparin-based anticoagulants, the use of treatments to try to reduce the level of the abnormal antibody causing this condition and the avoidance of the strategy of trying to bring the platelet count back to normal levels by giving platelet transfusions.

The researchers saw that patients given intravenous immunoglobulin, a treatment in which the body is flooded with natural antibodies in an attempt to reduce the effects of the abnormal body, were most effective.

But the researchers caution that although this type appears to be associated with better outcomes, one should be careful not to read too much into the results of an observational study.

They now want to advance to a randomized clinical trial to confirm their findings, and this comes after a recent population-based study commissioned by the European Medicines Agency (EMA) found that blood clotting events after receiving the AstraZeneca coronavirus vaccine were the same or less frequent than those who received the Pfizer vaccine. Pfizer mRNA.

In March, concerns were raised about blood clotting events associated with the AstraZeneca vaccine

One month later, the EMA's safety committee concluded that there may be a link between the AstraZeneca vaccine and very rare cases of unusual blood clots.

These rare blood clots occur in the veins of the brain, abdomen and arteries, as well as low levels of platelets.